Pharmacy benefit managers (PBMs) and insurers operating in Oregon are barred from restricting 340B drug dispensing or limiting the number [...] …
Year: 2024
A recent analysis of the increasing annual total number of drug manufacturer refunds to 340B covered entities notes they are [...] …
Drug manufacturer Teva this week added a blood therapy medication to its hospital contract pharmacy restrictions implemented last summer. The [...] …
While the Biden administration’s proposal to address drug shortages does not exempt certain drug products from 340B pricing like the [...] …
The Maryland and Kansas legislatures have each cleared bills that would prohibit drug manufacturer 340B contract pharmacy restrictions in their [...] …
The Mississippi state senate yesterday overwhelmingly cleared for the governor’s consideration a bill to prohibit drugmaker 340B contract pharmacy restrictions, [...] …
Sexually transmitted disease (STD) clinics in Tennessee may soon have to enter into contracts to receive 340B in-kind funding—and for-profit [...] …
SPONSORED CONTENT
Healthcare leaders have a lot on their plates. Today’s healthcare landscape requires health care organizations to compete in attracting and retaining qualified employees, remain up to date on reimbursement changes, select and employ technologies to serve more patients in convenient
…
Stakeholders disagreed on whether Congress should codify a new 340B patient definition or restrict how providers use 340B savings, in [...] …
The dozens of health systems suing the federal government over the reversal of a pandemic-era 340B child site registration waiver [...] …